Profitability Ratios
| Ratio |
Value |
| GP Margin |
51.6% |
| EBIT Margin |
36.6% |
| EBITDA Margin |
44.3% |
| Operating Margin |
29.6% |
| Pretax Margin |
36.6% |
| Cont. Ops Margin |
29.3% |
| Net Margin |
29.3% |
| Bottom Line Margin |
29.3% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
37.62 |
| Quick Ratio |
34.57 |
| Solvency Ratio |
4.349 |
| Cash Ratio |
33.01 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-1.33 |
| Forward PEG |
-1.33 |
| Price/Book |
1.52 |
| Price/Sales |
4.71 |
| Price/FCF |
12.66 |
| Price/Op Cash Flow |
12.34 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0018 |
| Debt/Equity |
0.0019 |
| Debt/Capital |
0.0019 |
| Long-Term Debt/Capital |
0.0000 |
| Financial Leverage |
1.03 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.41 |
| Operating Cash Flow Ratio |
5.655 |
| Operating Cash Flow/Sales |
38.1% |
| Free Cash Flow/Operating Cash Flow |
97.5% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
0.00 |
| Interest Coverage |
0.0000 |
| Short-Term Operating Cash Flow Coverage |
0.00 |
| Operating Cash Flow Coverage |
65.30 |
| Capital Expenditure Coverage |
39.60 |
| Dividend + Capital Expenditure Coverage |
3.37 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
35.2915% |
| Dividend Yield |
2.1968% |
| Dividend Yield % |
2.1968% |
| Dividend Per Share |
1.2293 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
11.89 |
| EPS |
3.483 |
| Debt/Share |
0.0694 |
| Cash/Share |
26.47 |
| Book Value/Share |
36.81 |
| Tangible BV/Share |
32.21 |
| Equity/Share |
36.81 |
| Operating Cash Flow/Share |
4.535 |
| Capital Expenditure/Share |
0.115 |
| FCF/Share |
4.420 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.800 |
| Earnings Before Tax/EBIT |
1.238 |
| Price/Fair Value |
1.52 |
| Debt/Market Cap |
0.0000 |
| Effective Tax Rate |
20.0% |
| Enterprise Value Multiple |
5.61 |
UTMD - Utah Medical Products, Inc.